Mrv1572009171518002D 17 16 0 0 0 0 999 V2000 7.6861 -0.2062 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.9716 1.0312 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.8281 -1.0312 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.3991 -0.2062 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 9.8295 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.5440 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.1150 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2585 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.4005 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.9729 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2571 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.5426 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.9716 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8281 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1137 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9562 0.0495 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 3.3991 -0.7177 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 9 1 0 0 0 0 1 13 1 0 0 0 0 2 13 2 0 0 0 0 3 14 2 0 0 0 0 4 15 1 0 0 0 0 4 16 1 0 0 0 0 4 17 1 0 0 0 0 5 6 1 0 0 0 0 5 7 1 0 0 0 0 6 8 1 0 0 0 0 7 9 1 0 0 0 0 8 10 1 0 0 0 0 11 12 1 0 0 0 0 11 13 1 0 0 0 0 12 14 1 0 0 0 0 14 15 1 0 0 0 0 M END > DB06261 > drugbank > [H]N([H])CC(=O)CCC(=O)OCCCCCC > InChI=1S/C11H21NO3/c1-2-3-4-5-8-15-11(14)7-6-10(13)9-12/h2-9,12H2,1H3 > RYQOILLJDKPETL-UHFFFAOYSA-N > C11H21NO3 > 215.293 > 215.15214354 > 3 > 36 > 24.960932917333498 > 1 > 1 > 0 > 1 > hexyl 5-amino-4-oxopentanoate > 1.55 > 1.3659431133333326 > -2.62 > 0 > 0 > 1 > 16.10674862594475 > 7.834133913242029 > 69.39 > 58.2925 > 10 > 1 > 5.11e-01 g/l > hexyl 5-amino-4-oxopentanoate > 0 > DB06261 > approved > Hexaminolevulinate > 4-Hexyloxycarbonyl-2-oxobutylammoniumchloride; Hexaminolevulinato; Hexyl 5-amino-4-oxopentanoate hydrochloride; Hexyl(5-amino-4-oxopentanoat)-hydrochlorid; Pentanoic acid, 5-amino-4-oxo-, hexyl ester, hydrochloride > Cysview > Hexvix > Hexaminolevulinate hydrochloride $$$$